Background In the USA, men who have sex men (MSM) are at high risk for HIV, and black MSM have a substantially higher prevalence of infection than white MSM. We created a simulation model to assess the strength of existing hypotheses and data that account for these disparities.
Introduction
Men who have sex with men (MSM) account for most new HIV diagnoses in the USA. 1 Concentrations of HIV infections among MSM are highest in southern USA, and Georgia is the only state that ranks in the top five for both percentage of MSM and absolute number of MSM living with a diagnosis of HIV. 2 The HIV epidemic in MSM is characterised by marked, long-standing racial disparities between black and white populations: in a study in Atlanta, GA, the estimated prevalence was 43% in black MSM and 13% in white MSM, a 3·3-fold disparity. 3, 4 Several explanations for the disproportionate effect of HIV among black MSM have been offered and thoroughly reviewed, 5, 6 including distal structural factors such as poverty, stigma, and institutionalised racism. However, the proximal causal pathways through which these factors enact disparate epidemics have proven challenging to elucidate. For structural factors to cause differentials in incidence of HIV infection, they must mediate one or both of two more proximal causes: the frequency with which HIV-negative individuals are potentially exposed to HIV, and the probability of transmission if exposed, which comprises factors associated with either the HIV-negative partner (eg, circumcision status) or the HIV-positive partner (eg, viral suppression).
Much work about racial disparities in HIV infection among MSM focuses on self-reported individual risk behaviours (eg, number of sex partners, substance use), and thus has limited explanatory power, because most behaviours are not more common in black MSM than white MSM. 5, 6 Inadequate HIV suppression among HIV-positive partners of HIV-negative MSM places them at increased risk of acquisition, with racial disparities in the care continuum probably contributing to racial disparaties in incidence. 7 Few studies of susceptibility differences have been done, although the CCR5Δ32 mutation, which is more prevalent in populations of European ancestry than of African ancestry, is protective against infection. 8 Differences in sexual-network properties are another potential set of explanations, although the primary evidence for meaningful differences by race is mixed. 4, 6, 9, 10 Stigma related to sexuality and HIV can also affect the health of black MSM and influence their apparent and real HIV risks by shortening partnership durations and suppressing discussion of HIV status before sex (ie, serodiscussion). Stigma and mistrust of research might cause under-reporting of risk-enhancing behaviours by black MSM: evidence suggests that correction for underreporting leads to equivalent, rather than lower, risks for black MSM compared with white MSM. 11 Race-assortative mixing (the tendency to select samerace partners) can enable disparities arising from other factors to remain concentrated within groups. Partner race is a strong explanatory factor in incidence studies, 12, 13 suggesting a role in facilitating persistence for existing disparities. 6, 7, 10 However, race-assortative mixing alone probably cannot sustain disparities arising from other sources. Modelling theory, including work on HIV and other sexually transmitted infections (STIs), predicts that a given epidemic typically heads towards a fixed equilibrium, irrespective of its current state. 14 For each subpopulation, a specific prevalence represents the point at which incident infections are balanced by deaths among people with HIV. We have built a web tool that shows this concept to build further intuition in the context of a simpler model (appendix). The theory suggests that, if race-assortative mixing alone cannot generate a disparity then it also cannot sustain a disparity indefinitely or cause increasing disparities over time. However, exceptions to this theory exist, and epidemic dynamics can be slow for lifelong infections like HIV. 15 The ability for reported levels of race-assortative mixing, in combination with other reported proximal factors, to generate racial disparities in HIV in MSM or maintain disparities over the long timeframes that they have been reported, has not been assessed. A study in which datadriven models were used to examine this question for young MSM over 15 years showed that racial differences in incidence of HIV infection narrowed over the course of the simulated epidemic. 16 Dynamic network models are well positioned to assess multiple proposed mechanisms for the ability to generate or sustain disparities, and have been called for. 7 We implemented a model parameterised by data from young MSM in Atlanta to answer two questions. First, assuming that disparities emerged from some unmeasured differences early in the epidemic, how long could they be sustained under reported race-assortative mixing, with or without other recorded racial differences? Second, how much of the 3•3-fold racial disparity in prevalence of
Research in Context
Evidence before this study Disparities in HIV infection between black and white populations have been a hallmark of the US HIV epidemic for decades, but to account for them fully has proved challenging. We searched PubMed with combinations of the keywords "HIV", "AIDS", "MSM", "men who have sex with men", "disparity", "disparities", "race", "racial", "ethnic", "ethnicity", "black", "African American", "white", and "Caucasian" for articles published in English on or before June 5, 2016 (the date of our final search). We focused on studies that discussed either the empirical evidence for, or sources and causal mechanisms of, disparities in incidence and prevalence of HIV infection between black and white men who have sex with men (MSM) in the USA. We found many empirical studies over decades that show the existence of these disparities, and several critical literature reviews and meta-analyses that show the existence and magnitude of many potential sources, including racial assortativity, proximal differences in the care cascade, sexual networking, and biological cofactors, and distal factors such as stigma and poverty. However, quantification of the magnitude of disparity that the many proximal sources could generate or sustain over time necessitates dynamic modelling, which the authors of many of the papers acknowledge and call for. One group of investigators developed a data-driven network model to assess disparities in very young (age 16·0-21·8 years) MSM during a 15 year timeframe, but they did not attempt to partition the detected disparities attributed to each of the proposed sources, or to estimate the proportion unexplained. Additionally, the authors of a series of theoretical modelling papers laid out the expected relations between the generation and maintenance of disparities, although these relations have not been verified in the specific context of racial disparities in HIV infection in US MSM.
Added value of this study
Our study is the first to show in a dynamic model that a combination of many proposed proximal sources of racial disparities in HIV among US MSM generate a reverse disparity. We quantified the amount that each component, in combination with race assortativity, contributes to observed or reverse disparities, with the care cascade, biological cofactors, HIV serostatus disclosure, and some aspects of partnership dynamics each contributing a substantial amount to the observed disparity. We showed that misclassification within other behavioural components would be sufficient to generate the observed prevalence of HIV among black MSM. We examined the power of these causes to generate and sustain disparities, and showed that the ability to sustain pre-existing disparities on their own is short-lived.
Implications of all the available evidence
We provide the most thorough assessment so far of the ability for proposed sources to either generate or sustain observed racial disparities in HIV among US MSM in the long term. High incidence of HIV infection among black MSM is one of the most pressing public health concerns, and reduction of this burden is a priority in the US National HIV/AIDS Strategy. We provide novel evidence for the relative importance of the proximal sources to this high burden, a necessary first step in determining the effectiveness of efforts to reduce that burden. We also show how much these sources cannot explain, highlighting the areas where more evidence is crucially needed.
HIV infection could be generated by specific measured proximal factors, alone or in combination? We also further explore our findings for the second question to consider the potential effect of behaviour misclassification caused by societal factors.
Methods

Model design
We used dynamic, stochastic network models that extend previous work. 17 We began with 10 000 MSM, each of whom possessed fixed (eg, race, circumcision status, CCR5Δ32 status) and dynamic (eg, age, infection status) attributes. Men with HIV had additional dynamic attributes (eg, diagnosis status, treatment status, stage, viral load). We simulated multiple transitions for each man by week, concurrently with relational dynamics (panel). Models simulated three contact networks for anal intercourse: main partnerships, casual partnerships with repeat contacts, and one-time contacts. These simulations employed separable-temporal exponential random graph models, 18 implemented in the R package suite Statnet and the R package EpiModel. These methods allow fine control over several relational structures, including dependencies among having partners of each type. Tables 1 and 2 include modelled relational structures. Behavioural, demographic, and carecontinuum parameters varied by race, or for counterfactual analyses were averaged across races. We modelled each scenario 16 times, with race-specific outcomes tracked until reaching equilibrium prevalence (appendix).
Data sources
We obtained race-specific risk and prevention behaviours and network attributes from two studies of HIV disparities between black and white MSM and in Atlanta that were done in 2010-14 (tables 1, 2). 4, 13, 19 Involvement was a prospective HIV incidence cohort (n=803); the MAN Project was a cross-sectional chain-referral sexual Departures due to background mortality Occurs with age-specific and race-specific all-cause mortality rates
Departures due to HIV mortality
Occurs as a complex function of time since infection off treatment, on treatment and fully suppressed, and on treatment and partly suppressed
Main and casual partnership formation
Modelled with exponential random graph models, occur in patterns that maintain the race-specific cross-sectional distribution of partner counts, race mixing, and age mixing from our data
Main and casual partnership dissolution
Modelled with exponential random graph models, occur in patterns that maintain the race-specific partnership-typespecific relational durations Anal intercourse within main and casual partnership Drawn each week for each relationship from a Poisson distribution with means specific to race combination and relational type One-time anal intercourse contact Drawn each week with probabilities that maintain race and age mixing, and with individuals' one-time contacts a function of their race, count of ongoing partnerships, and individual propensity HIV status disclosure Modelled at the level of the relational pair, function of the races of the pair, relational type, and whether diagnosis occurs before or after the start of relationship
Condom use
Determined separately for each act, function of races of pair, relation type, and diagnosis and disclosure status of partner with HIV Sexual role selection Function of individual propensities, which vary by race; bi-directional anal intercourse allowed
Transmission
Probabilities depend on condom use; infection stage, viral load, and sexual position of the partner with HIV; and the HIV-negative partner's circumcision status (if insertive) and CCR5Δ32 genotype
Viral dynamics
Largely follow those of previous models 17 and depend on time since infection and treatment status
HIV testing
Small race-specific percentage of men never test; for those who do, intertest intervals are race-specific
Treatment initiation
Contingent on diagnosis; timing after diagnosis varies by race
Treatment cessation and reinitiation
Occur at race-specific rates to maintain reported prevalence of treatment and durable treatment by race Suppression Can occur at partial or full levels, at race-specific frequencies For Statnet see https://statnet. org/trac/wik For EpiModel see www.epimodel. org networks study (n=314). 4, 13, 19 Venue-time-space sampling was used for both (in the MAN Project, it was used for network-seed-level respondents). We included MSM from the baseline visit in Involvement and seeds from the MAN Project. Because these disparity-focused studies addressed MSM aged 18-39 years, the main timeframe during which HIV disparities appear, our model does so also.
Participants completed self-administered computerbased questionnaires assessing demographics and prevention and risk behaviours for themselves and their most recent sexual partners (Involvement, up to five in the previous 6 months; MAN Project, up to ten in 12 months). 4 We measured dyadic behaviours for presexual, ongoing relationship, and last-sex periods. Analyses included only dyads in which anal intercourse occurred at least once (n=2626 dyads). We obtained treatment and efficacy parameters from published literature (appendix). We adopted susceptibility estimate for CCR5Δ32 heterozygotes from the only MSM-specific study, 8 which showed a stronger effect than reported in studies of heterosexual people, because our model focused on MSM and our goal was to estimate maximum potential explanatory power for hypothesised factors.
Black MSM reported lower levels of sexual risk behaviours than did white MSM, consistent with published work and reports from the two source studies.
3,4,13,19 However, the mean duration of black MSM's relationships was consistently shorter than that of white MSM's relationships, and serodiscussion was less common in black than in white MSM, possibly reflecting differences resulting from stigma. 20 We thus combined sexual behaviours into two groups: stigma-associated behaviours that generally favour greater transmission for black MSM, and most other sexual behaviours, which are reported more commonly by white MSM. Table 3 outlines scenarios, all of which included race-assortative mixing at reported levels (~90% of relationships withinrace across all partner types).
We did not aim to project the future or to recreate past temporal trajectories (which would require highly detailed historical data that are not available). Rather, our aims are framed within a context in which disparities in HIV burden have long existed at high levels, and in which disparities in many determinants have been examined in isolation across various study designs. For our first question (ie, how long could racial disparities in HIV infection be sustained under reported race-assortative mixing?) simulation duration has an explicit meaning. For our second question (ie, how much of the racial disparity in prevalence could be generated by specific measured proximal factors?) we focus on equilibrium, which represents the maximum disparity a scenario can generate or sustain. Intervention models often include a calibration step in which model parameters are varied to obtain historical prevalence before beginning intervention rollout. Instead, by design, we estimated all parameters from data sources, without calibration, because the ability of observed factors to generate observed prevalence by race and the disparity between them is precisely the objective.
For our first question, we specified networks in which the prevalence of HIV is 43% in black MSM and 13% in white MSM, matching that in Involvement. 4 We set all behaviours for black and white MSM to betweenrace mean values (ie, a null scenario), with reported levels of race assortativity. We repeated the simulations with all parameters set to observed race-specific values (ie, as observed).
For our second question, we created initial networks in which the prevalence of HIV infection in both black and white MSM was 5%, and did the simulation under all scenarios in table 3. Every scenario included race assortativity. By grouping the modelled factors and assigning either observed race-specific values or mean values averaged across races, we probed the disparity generated by all hypothesised factors together (ie, as observed), each factor group in isolation, and combinations of factor groups. The final scenario set sexual behaviours in black MSM as equivalent to those in 
HIV care continuum
CCR5Δ32
Stigma-associated behaviours
Majority of sexual behaviours
Residual determinants
Null (all factors set to between-race mean) -
As observed (all factors race-specific) white MSM, to probe the potential effects of misreporting due to increased social desirability bias in minority respondents. 11, 21, 22 We began these runs with low, equal prevalence to test whether these scenarios could generate a disparity. We then repeated specific runs, starting with observed race-specific prevalence, to confirm that the final disparity was insensitive to initial prevalence, as predicted by modelling theory (appendix). The model code is available online.
Role of the funding source
The study funder had no role in study design; data collection, analysis, or interpretation; or writing of the Article. The corresponding author had access to all deidentified data used in the study and had final responsibility for the decision to submit for publication.
Results
For our null model beginning with observed race-specific prevalence, incidence was initially higher in black MSM because of the difference in prevalence in partners.
Subsequently, incidence and prevalence converged, with prevalence disparity falling to half the initial disparity in 6•7 years, and by over 90% in 22 years ( figure 1A, 1B) . When all parameters were set to observed race-specific values (ie, as observed), disparities disappeared even more quickly (the disparity in prevalence fell by 50% and 90% in 3•3 years and 9•7 years, respectively), and equilibrium prevalence was higher for white than for black MSM ( figure 1C, 1D) . Table 4 shows results for how much of the 3•3-fold racial disparity in prevalence could be generated by specific measured proximal factors, alone or in combination. Figure 2 shows the race-specific prevalences for the same models, relative to observed results in the Involvement trial. Leaving all parameters as observed by race yielded mean prevalences of HIV infection in black and white MSM identical to those obtained with as-observed parameters seeded with observed prevalences. The same was true for the null scenario. This finding supports the extension of basic modelling theory to our more complex case: the set of race-specific equilibrium prevalences is These scenarios probe the ability for pre-existing disparities that could have been generated early in the epidemic to be sustained, either by assortative mixing alone (ie, the null model) or by the full set of race-specific behavioural, biological, demographic, and clinical conditions as drawn from our studies and published work (ie, the as-observed scenario). Initial prevalence by race is set to that observed in our source data. Individual lines represent each of 16 simulations; thick lines represent means. MSM=men who have sex with men. independent of initial (non-zero) prevalence, and these scenarios cannot sustain pre-existing disparities larger than those they generate. We provide an additional example and detail in the appendix. We next considered the power of each factor group in explaining the observed disparity. Differences in the care continuum, CCR5Δ32 status, and stigma-associated behaviours each explained a substantial disparity. However, the majority-of-sexual-behaviours scenario did the opposite, yielding substantially lower prevalences in black than in white MSM. Racial differences in residual determinants (eg, circumcision, background mortality) yielded only a slight disparity. Most scenarios yielded a prevalence of HIV in white MSM close to observed prevalence, but the majority-of-sexual-behaviours scenarios overestimated it. Prevalence in black MSM was underestimated by all models.
When factor sets were combined, nearly half the disparity was explainable by biomedical determinants, and about a sixth by care and disclosure factors. The scenario varying all sexual behaviours by race yielded the same magnitude reverse disparity as most sexual behaviours alone (0·39 and 0·40, respectively, with overlapping IQRs). The all-risk-factors-in-black MSM scenario, which assessed a priori race-specific factor values that would favour higher prevalence in black than in white MSM, yielded a large disparity, and was the only scenario to include individual runs with a disparity within the observed data's confidence interval. The various factor sets generally yielded prevalences in white MSM close to observed prevalence, except for the all sexual behaviours scenario. Some factor sets yielded prevalences in black MSM closer to observed prevalence than factor groups individually; all were still underestimates, however.
In a scenario probing the misclassification of risk behaviours, in which all values were as observed by race but black MSM were assigned values reported by white MSM for most sexual behaviours, mean prevalence in black MSM closely matched the observed 43·4% prevalence. However, prevalence in white MSM was higher than observed, generating a smaller-than-expected disparity.
Discussion
We used data from Atlanta-based studies focused on racial disparities in HIV prevalence and a previously described model structure 17 to assess whether the hypotheses that have been put forward in scientific literature (average differences in networks of sexual relationships, sexual behaviours within relationships, the care cascade, disclosure, and CCR5 genotype frequencies) are sufficient to explain the observed disparities. We found that these hypothesised explanatory factors accounted for, at most, 55·5% of observed disparities (table 4) . Data are n/N, unless otherwise specified. For observed values (ie, the first row), we report 95% CIs; all other data are reported with the IQR. For simulated prevalence numbers, values represent the mean (IQR) observed at the end of the 16 simulations, with initial population size of 10 000. Simulated prevalence ratios are calculated separately at the end of each of the 16 runs and are reported as mean (IQR). For percentage of disparity explained, we compared the mean (IQR) of the 16 simulated prevalence ratios with the observed point estimate, using the formula (PR sim -1)/(PR obs -1), where PR sim is the simulated prevalence ratio and PR obs is the observed prevalence ratio. For scenarios in which all simulations yielded a larger prevalence of HIV infection for white than for black MSM, we report the percentage disparity as N/A. The percentage disparity explained for the null model should be centered on 0, with stochasticity, by design. MSM=men who have sex with men. N/A=not applicable. Table 4 : Racial disparity in prevalence of HIV infection generated by specific measured proximal factors, alone or in combination
All else being equal, race-assortative mixing patterns in MSM cannot generate or sustain a racial disparity, let alone promote increased disparities over time. Our findings suggest that race-assortativity, along with preexisting prevalence disparities, are an insufficient explanation for population-level race disparities in incidence of HIV infection. However, the lack of population-level explanatory ability is different from the explanatory ability of prevalence among partner populations to predict short-term race-specific individual-level risk. In incidence studies, 13 prevalence of HIV infection in specific partner pools (eg, black partners, 13 older partners 12 ) remains a strong individual predictor of HIV acquisition. We urge that such associations not be used to stigmatise groups with higher prevalences but rather to reinforce the urgent need for approaches that improve the health of everyone living with, or at risk of, HIV, while respecting the dignity of all affected communities. 4, 13, 23 Low engagement in HIV care engagement and low attainment of viral suppression in black MSM explained a meaningful proportion of disparities in prevalence. Other researchers have described the components of care and how social and structural factors, such as poverty and access to transportation, are associated with care outcomes.
3 These findings underscore the urgency of achieving the US National HIV/AIDS Strategy goal of increasing access to care, which would help to achieve the goals of reducing new infections and HIVrelated disparities. 24 Prospective studies are needed to understand more fully the reasons for racially disparate HIV care outcomes among MSM and to develop interventions addressing the entire care continuum for MSM. Despite the importance of HIV care in explaining prevalence disparities, 3,7 these disparities existed before the availability of effective combination treatments, supporting the contribution of other factors. 25 We found that the CCR5Δ32 mutation had a large potential role in disparities in prevalence between black and white MSM. This role hinged on the inclusion of a partly protective effect for the heterozygous genotype. A meta-analysis of predominantly small, diverse studies 26 did not show a consistent protective effect for heterozygosity, but importantly did not include the only racefocused study of US MSM that informed our parameter. 8 The immutable nature of genetic differences presents a programmatic and messaging challenge. Because other groups with lower prevalence (eg, Asian Americans) also lack deletion genotypes, the ability for genetic differences alone to produce HIV disparities is probably limited, but we have shown their potential to operate in concert with other factors to yield substantial disparities. 6 Relatedly, we did not consider STIs to be biological cofactors, given the additional model complexity and overlap with causal and associative mechanisms for HIV that would result. Results from Involvement showed high and similar racially disparate incidences of gonorrhoea, 
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Biomedical determinants Care and disclosure All sexual behaviours All risk factors in black MSM Misclassification chlamydia, and syphilis, and statistical modelling suggested that rectal STIs explained 15% of subsequent HIV infection. 4, 27 In that work, increased HIV transmission from co-infected MSM was not considered. Models incorporating STIs might be expected to yield greater racial disparities in prevalence of HIV, and are in development.
Our analysis provides several new insights into the role of risk behaviours in epidemics in MSM. Modelling only the set of risk behaviours at observed levels, which are generally reported less commonly in black than in white MSM, produced an inverse disparity. That this disparity was nearly identical to the scenario with all factors as observed shows the strong leverage for risk behaviours in determination of disparities, which masks the role of biomedical factors in creation of disparities. When modelling equal, rather than lower, behavioural risks for black and white MSM, the direction of disparity was reversed and population-observed prevalence in black MSM was obtained, suggesting that under-reporting could potentially help to explain disparities. Racial differences in reporting have been discounted because of the qualitative consistency of reports across time and geography, but validation studies have shown under-reporting. 6, 11, 21, 22 Further understanding of the social determinants of under-reporting and development of risk biomarkers in studies in MSM are needed. 28 Two behaviours that are postulated to be influenced by stigma (reduced HIV serodiscussion and shorter partnership duration) worked differently from other behaviours. When considered separately, they yielded a modest disparity, showing a mechanism through which stigma can shape HIV risk in black MSM.
Our model did not explain the full magnitude of disparities reported in surveillance and research studies, and we suggest several possible sources not accounted for in our model, beyond STIs. We incorporated the only published, nationally representative estimates of care engagement among MSM by race, derived from US Centers for Disease Control and Prevention data sources, because relevant Atlanta-specific data were unavailable. Such Atlanta-specific data might show greater racial differences in engagement and viral suppression. This lack of data emphasises the need for improved care continuum surveillance for all racial groups of MSM at all jurisdictional levels. We modelled race-assortative mixing probabilities as uniform within race; individual heterogeneity in the propensity for interracial partnerships, attributable to residential or cultural segregation, could amplify disparities.
Although our model represents black and white MSM in Atlanta, our initial population size (n=10 000) is smaller than those communities. However, models for infectious diseases like STIs, for which contact rates do not scale with population size are generally robust to size above a small threshold (on the order of n=1e³). 29 Nevertheless, we re-ran our main scenario with populations of 5000 and 20 000 (data not shown), and the results were consistent with our findings.
Because we focused on MSM aged younger than 40 years, disparity convergences were faster than would be observed in reality. We did not model HIV preexposure prophylaxis, an effective biomedical prevention modality, because observed disparities pre-date regulatory approval. Elsewhere we extend our framework to consider pre-exposure prophylaxis, 30 with subsequent work addressing its effect on racial disparities.
High incidence of HIV infection among black MSM is one of the most pressing public health concerns in the USA and a national priority. 24 Our model shows the roles of access to effective HIV care, biological susceptibility, and behaviours in influencing this risk. We show that some residual sources of disparity remain unexplained and require further exploration if health equity is to be achieved. Programmes and policies must emphasise expanded access to antiretroviral therapies for HIV treatment and prophylaxis, while seeking to alleviate underlying social determinants and stigmas that shape black MSM's HIV risks. Our results confirm that the goals of the US National HIV/AIDS Strategy, if achieved, hold substantial potential to reduce HIV disparities by race among MSM.
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